Loading…
OraSure Technologies' subsidiary DNA Genotek entered into a $143 million agreement to supply its Oragene Dx saliva DNA collection devices to a leading consumer genomics customer.
Grifols has restated its 2005 agreement with OraSure Technologies for a five-year extension to supply recombinant antigens for OraSure's OraQuick HCV Rapid Antibody Test.
OraSure has received an $18 million product supply contract with an unnamed foreign country to support a nationwide hepatitis C testing and treatment program. Deliveries will occur over 12 months through late 2017, with an option to extend through 2018.